Back To: Home

CLICK HERE FOR WHAT'S NEW IN:
 




 

GSK launches Boston-based biotech
June 2009
SHARING OPTIONS:

CAMBRIDGE, Mass.—London-based pharma GlaxoSmithKline plc last month announced the spin-off of Tempero Pharmaceuticals from GSK's Immuno-Inflammation Centre of Excellence in Drug Discovery. The new company will be based in Cambridge, Mass and focus on advances in T-cell biology to develop novel medicines for inflammatory and autoimmune diseases. Further details on the spin-off were not disclosed.

Back



PAGE UTILITIES


CONTACT US
DDNEWS
1000 N West Street, Suite 1200,
Wilmington, Delaware, 19801
Ph: 888-781-0328 |  Fax: 705-528-0270
 
© Copyright 2020 Old River Publications LLC. All righs reserved.  |  Web site managed and designed by OffWhite.